Waldencast (NASDAQ:WALD) Research Coverage Started at TD Cowen

TD Cowen assumed coverage on shares of Waldencast (NASDAQ:WALDFree Report) in a research report sent to investors on Monday morning, MarketBeat.com reports. The firm issued a hold rating and a $4.30 target price on the stock.

WALD has been the subject of several other research reports. DA Davidson increased their target price on shares of Waldencast from $7.25 to $7.50 and gave the stock a “buy” rating in a report on Wednesday, December 4th. Canaccord Genuity Group raised their price objective on Waldencast from $5.00 to $6.00 and gave the company a “buy” rating in a report on Friday, November 22nd. Telsey Advisory Group reaffirmed an “outperform” rating and set a $6.00 price target on shares of Waldencast in a research report on Monday, November 18th. Finally, Canaccord Genuity Group started coverage on shares of Waldencast in a research note on Friday, October 25th. They issued a “buy” rating and a $5.00 price target for the company. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $5.76.

Check Out Our Latest Report on WALD

Waldencast Trading Down 9.5 %

Shares of Waldencast stock opened at $3.53 on Monday. The business’s 50 day simple moving average is $3.45 and its 200 day simple moving average is $3.52. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.47 and a quick ratio of 0.78. Waldencast has a 52-week low of $2.40 and a 52-week high of $12.00.

Institutional Trading of Waldencast

Hedge funds have recently modified their holdings of the stock. Point72 Asia Singapore Pte. Ltd. grew its stake in Waldencast by 293.9% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,854 shares of the company’s stock valued at $25,000 after buying an additional 5,114 shares during the last quarter. Marshall Wace LLP acquired a new position in shares of Waldencast in the second quarter valued at approximately $37,000. Catalina Capital Group LLC bought a new position in shares of Waldencast during the third quarter worth approximately $58,000. McAdam LLC acquired a new stake in Waldencast during the 3rd quarter worth approximately $62,000. Finally, Cubist Systematic Strategies LLC bought a new stake in Waldencast in the 2nd quarter valued at $85,000. Institutional investors and hedge funds own 41.97% of the company’s stock.

About Waldencast

(Get Free Report)

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.

Read More

Analyst Recommendations for Waldencast (NASDAQ:WALD)

Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.